President Donald Trump issued an executive order in April 2026 titled "Accelerating Medical Treatments for Serious Mental Illness," which directed federal agencies to accelerate research into psychedelic medicine.

Depression, anxiety, suicide prevention, youth mental health, therapeutic approaches, neurodiversity, and access to psychiatric care.

Mind-altering substances like psilocybin, LSD, MDMA, and ayahuasca and their therapeutic and cultural use.